Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

GSK

Gsk (GSK)

Gsk Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:GSK
DateTimeSourceHeadlineSymbolCompany
07/19/20245:36AMRNS Regulatory NewsGSK PLC Blenrep EMA Filing AcceptanceLSE:GSKGsk Plc
07/19/20243:12AMAlliance NewsAlliance NewsGSK drug for multiple myeloma accepted for European regulatory reviewLSE:GSKGsk Plc
07/19/20243:12AMAlliance NewsAlliance NewsGSK drug for multiple myeloma accepted for European regulatory reviewLSE:GSKGsk Plc
07/18/202410:30AMRNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
07/16/202410:30AMRNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
07/15/202410:30AMRNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
07/14/20246:18AMAlliance NewsAlliance NewsGSK moves to new global headquarters in return to central LondonLSE:GSKGsk Plc
07/14/20246:18AMAlliance NewsAlliance NewsGSK moves to new global headquarters in return to central LondonLSE:GSKGsk Plc
07/12/202410:30AMRNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
07/08/20248:32AMAlliance NewsAlliance NewsIN THE KNOW: UBS downgrades GSK and hacks share price targetLSE:GSKGsk Plc
07/08/20248:32AMAlliance NewsAlliance NewsIN THE KNOW: UBS downgrades GSK and hacks share price targetLSE:GSKGsk Plc
07/03/20244:22AMAlliance NewsAlliance NewsTOP NEWS: GSK inks licensing deal with CureVac for flu and Covid drugsLSE:GSKGsk Plc
07/03/20244:22AMAlliance NewsAlliance NewsTOP NEWS: GSK inks licensing deal with CureVac for flu and Covid drugsLSE:GSKGsk Plc
07/03/20242:00AMRNS Regulatory NewsGSK PLC GSK and CureVac collaboration restructuredLSE:GSKGsk Plc
07/01/202410:00AMRNS Regulatory NewsGSK PLC Total Voting RightsLSE:GSKGsk Plc
06/28/20242:43PMAlliance NewsAlliance NewsIN BRIEF: GSK reaches settlement over Zantac case in IllinoisLSE:GSKGsk Plc
06/28/20242:43PMAlliance NewsAlliance NewsIN BRIEF: GSK reaches settlement over Zantac case in IllinoisLSE:GSKGsk Plc
06/28/202412:37PMRNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
06/24/20243:55AMAlliance NewsAlliance NewsTOP NEWS: GSK hails Omjjara approval in Japan; Jemperli review in EULSE:GSKGsk Plc
06/24/20243:55AMAlliance NewsAlliance NewsTOP NEWS: GSK hails Omjjara approval in Japan; Jemperli review in EULSE:GSKGsk Plc
06/24/20242:05AMRNS Regulatory NewsGSK PLC Omjjara approved in Japan for myelofibrosisLSE:GSKGsk Plc
06/24/20242:00AMRNS Regulatory NewsGSK PLC EMA validates Jemperli marketing authorisationLSE:GSKGsk Plc
06/21/202410:30AMRNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
06/12/202410:30AMRNS Regulatory NewsGSK PLC Director/PDMR ShareholdingLSE:GSKGsk Plc
06/11/20244:32AMAlliance NewsAlliance NewsTOP NEWS: GSK takes first steps to appeal Zantac ruling in DelawareLSE:GSKGsk Plc
06/11/20244:32AMAlliance NewsAlliance NewsTOP NEWS: GSK takes first steps to appeal Zantac ruling in DelawareLSE:GSKGsk Plc
06/11/20242:00AMRNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
06/10/20242:00PMAlliance NewsAlliance NewsTOP NEWS: GSK welcomes dismissal of Zantac case in IllinoisLSE:GSKGsk Plc
06/10/20242:00PMAlliance NewsAlliance NewsTOP NEWS: GSK welcomes dismissal of Zantac case in IllinoisLSE:GSKGsk Plc
06/10/20241:27PMRNS Regulatory NewsGSK PLC Statement: Zantac (ranitidine) litigationLSE:GSKGsk Plc
 Showing the most relevant articles for your search:LSE:GSK

Your Recent History

Delayed Upgrade Clock